A) The use of embryonic stem cells. B) The ease of obtaining stem cells from adults. C) The lack of potential applications. D) The uncontroversial ethical implications.
A) Ignoring public opinions and concerns. B) Funding from private corporations only. C) Speed of research progress above all else. D) Ethical guidelines and regulations.
A) To hinder progress in the field. B) To avoid sharing scientific breakthroughs. C) To address regulatory disparities and ensure ethical standards. D) To eliminate competition among research institutions.
A) Advocating for unrestricted research with no ethical oversight. B) Providing expertise on ethical implications and considerations. C) Serving as decision-makers for all stem cell research projects. D) Opposing all forms of medical research involving stem cells.
A) Developing international policy guidance on stem cell research. B) Promoting unregulated stem cell experimentation. C) Creating financial barriers to stem cell research. D) Excluding patient advocates from the research process.
A) Pluripotent cells are more versatile than totipotent cells. B) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell. C) Pluripotent cells can only divide a limited number of times. D) There is no difference between the two types of stem cells.
A) Create artificial intelligence using stem cells. B) Speed up the aging process in patients. C) Repair, replace, and regenerate damaged cells or tissues. D) Replace traditional medicine for all illnesses.
A) To ignore public opinions and concerns. B) To only focus on economic factors. C) To address diverse views on ethics, religious beliefs, and values that impact policy decisions. D) To prioritize scientific progress over societal implications. |